Japan’s CBD Industry Recieves First Investments From Publicly Listed Companies Following13.12.2024 09:36:45 CET | news aktuell GmbH | Pressmeddelande
AstraSana Japan Co., Ltd. has formed a capital and business alliance with Japan’s GSI Creos Corporation, bolstered by their investment. This partnership will enhance the wholesale distribution of CBD raw materials across Japan, leveraging the strengths of both companies. Through this alliance, the AstraSana Group, headquartered in Switzerland, will establish a robust supply chain to deliver Swiss-made, high-quality CBD raw materials across Japan, with a mission is to ensure customers receive safe, reliable products of the highest standard. Through this alliance, AstraSana Group (headquartered in Switzerland) will establish a stable supply chain to deliver Swiss-made, high-quality CBD raw materials nationwide in Japan. We aim to provide safe and reliable products to our customers. By leveraging GSI Creos’ extensive resources and networks, AstraSana says it will offer even higher-quality services to customers. Based on this robust partnership, it will actively contribute to the growth an